Skip Navigation LinksHome > March 2012 - Volume 27 - Issue 2 > Efficacy of metformin for prevention of weight gain in psych...
Text sizing:
A
A
A
International Clinical Psychopharmacology:
doi: 10.1097/YIC.0b013e32834d0a5b
Reviews

Efficacy of metformin for prevention of weight gain in psychiatric populations: a review

Newall, Hannaha; Myles, Nicholasa; Ward, Philip B.b; Samaras, Katherinec,d; Shiers, Davidf; Curtis, Jackieb,e

Collapse Box

Abstract

There is uncertainty with regard to the appropriate use of metformin for the prevention and management of second-generation antipsychotic-induced weight gain and metabolic abnormalities. We aim to systematically review the primary literature and to provide recommendations with regard to the use of metformin in psychiatric populations prescribed second-generation antipsychotics. The authors undertook a literature search of Medline, EMBASE, and PsycINFO using the search terms; antipsychotic OR atypical antipsychotic AND weight AND metformin. Narrative review was undertaken without additional statistical analysis. The search provided 198 results from which 10 original research papers were identified: six randomized controlled trials and one open-label study for adults and two randomized controlled trials and one open-label study for children and adolescents. Four meta-analyses were also identified. We concluded that if weight gain occurs after second-generation antipsychotic initiation, despite lifestyle intervention, metformin should be considered. Further studies with adequate statistical power are required to determine the efficacy of metformin in those with chronic psychotic illness.

© 2012 Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.